Share price
$5.97
As of Apr 29, 2026
ALGS | NASDAQ
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) | runway 7.4 months | financing risk elevated | market cap $38.9M. Daily snapshot of financials, capital pressure, and recen...
Company websiteLast updated Apr 29, 2026
Market cap
$38.9M
Snapshot valuation
30D volume
306,370 shares
Rolling average daily volume
Runway
7.4 months
Estimated from precomputed burn and cash
Financing risk
N/A
Current liquidity and financing setup suggest the company may need fresh capital in the near term.
Snapshot summary
Runway: 7.4 months based on estimated burn.
Financing signal: Current liquidity and financing setup suggest the company may need fresh capital in the near term.
Latest development: Aligos Therapeutics, Inc. 8-K 2026-04-21.
Recent developments
Aligos Therapeutics, Inc. 8-K 2026-04-21
8-K filed on 2026-04-21.
Aligos Therapeutics, Inc. 8-K 2026-04-14
8-K filed on 2026-04-14.
Aligos Therapeutics, Inc. 10-K 2026-03-05
10-K filed on 2026-03-05.
Aligos Therapeutics, Inc. 8-K 2026-03-05
8-K filed on 2026-03-05.
Aligos Therapeutics, Inc. 8-K 2026-02-04
8-K filed on 2026-02-04.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Aligos Therapeutics, Inc. 8-K 2026-04-21
8-K filed on 2026-04-21.
Apr 20, 2026Open source
Aligos Therapeutics, Inc. 8-K 2026-04-14
8-K filed on 2026-04-14.
Apr 13, 2026Open source
Aligos Therapeutics, Inc. 8-K 2026-03-05
8-K filed on 2026-03-05.
Mar 4, 2026Open source
Aligos Therapeutics, Inc. 10-K 2026-03-05
10-K filed on 2026-03-05.
Mar 4, 2026Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures